Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00396188 · ClinicalTrials.gov registry record
Screening Aid to Identify Corneas That May Have Pathologies or Other Conditions
A clinical trial, sponsored by Carl Zeiss Meditec.
- Completed
- Registry status
- 769
- Enrollment target
NCT00396188 is a clinical trial that has completed, run by Carl Zeiss Meditec. The registered enrollment target is 769 participants.
The verdict
NCT00396188 has completed, sponsored by Carl Zeiss Meditec.
- COMPLETED
- Registry status
- 769 participants
- Enrollment target
Study Summary
The purpose of this study is to determine the ability of a proprietary software screening tool to discriminate normal corneas (front surface of the eye) from previously diagnosed corneal conditions (diseases/surgeries/pathologies) and to determine the repeatabiltity and reproducibility of the Atlas II corneal topographer in normal human corneas.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 769 participants |
| Start Date | 2007-02 |
| Est. Completion | 2008-02 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00396188
The ClinicalTrials.gov registry entry for NCT00396188 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 769 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Carl Zeiss Meditec, which has 18 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00396188 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00396188 about?
NCT00396188 is a clinical study titled "Screening Aid to Identify Corneas That May Have Pathologies or Other Conditions". The purpose of this study is to determine the ability of a proprietary software screening tool to discriminate normal corneas (front surface of the eye) from previously diagnosed corneal conditions (diseases/surgeries/pathologies) and to determine the repeatabiltity and reproducibility of the Atlas ...
What is the current status of trial NCT00396188?
This trial is currently completed. The enrollment target is 769 participants. The study started on 2007-02. Estimated completion is 2008-02.
Who is sponsoring clinical trial NCT00396188?
This trial is sponsored by Carl Zeiss Meditec, which has 18 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.